Palomar Has Carved Out a Fast-Growing Insurance Niche -- Is it a Buy?
The company has carved out a niche in writing insurance in underserved markets with few direct competitors.
MarketAxess Has Changed the Game in Bond Trading. Is it a Buy?
MarketAxess' electronic trading platform is earning it more market share -- and its valuation is growing, too.
Progressive Is Crushing It Again in 2020 -- Is It a Buy?
The company is great at underwriting insurance because of tight control over its combined ratio and less reliance on investment income than competitors, leading to higher profit margins.
Is MSCI a Buy?
The company leverages its knowledge and expertise to provide exceptional products to the financial industry while growing its subscription-based revenues year after year.
ESG Investing Could Drive New Growth for BlackRock
The company has made a major shift toward sustainable investing available to customers on a large scale through its iShares ETFs.